Caxton Associates

SOUTH SAN FRANCISCO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the closing of a private placement of $5.0 million of units consisting of convertible preferred stock and common stock warrants on October 30, 2009. This closing constitutes the second tranche of the private placement of up to $43.5 million of Sunesis' securities announced in April 2009. The private placement contemplated the sale of up to $15.0 million of units consisting of convertible preferred stock and warrants to purchase common stock, of which $10.0 million of units were sold in the initial closing in April 2009 and the remaining $5.0 million of units were sold in the second closing held on October 30, 2009. The remaining tranche of up to $28.5 million of common stock may be invested at the election of the holders of a majority of the convertible preferred stock, in their sole discretion ...

RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwire - Sept. 8, 2009) - Adherex Technologies Inc. (TSX: AHX), announced today that the Company has appointed Robert Andrade as its new Chief Financial Officer. "I have known Robert professionally for more than 12 years. He has a solid financial background required for the new corporate direction of the Company," said Rosty Raykov, CEO of Adherex. Mr. Andrade, an existing Vice President and Board member of Adherex, is an accomplished executive with over 12 years of relevant financial experience that ...

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (MARKET WIRE) -- 09/08/09 -- Adherex Technologies Inc. (TSX: AHX), announced today that the Company has appointed Robert Andrade as its new Chief Financial Officer. "I have known Robert professionally for more than 12 years. He has a solid financial background required for the new corporate direction of the Company," said Rosty Raykov, CEO of Adherex. Mr. Andrade, an existing Vice President and Board member of Adherex, is an accomplished executive ...

LITTLETON, Mass., Sept. 8 /PRNewswire/ -- Still River Systems, Inc., a privately held medical device manufacturer developing a revolutionary, affordable proton therapy delivery system for the treatment of cancer, today announced that the company has appointed Joseph K. Jachinowski as its Chief Executive Officer and to its Board of Directors. Joe comes to Still River Systems with a distinguished 28 year track record of successfully developing products and building companies in the field of radiation therapy for cancer. He was most recently Executive Vice President of Elekta AB and CEO of Elekta Holdings with overall responsibility for all of Elekta's ...

Times were tough for most investors in 2008, but not for the top money managers on "Alpha" magazine's 8th annual ranking of the world's highest-earning hedge fund managers.

These top hedge fund managers, on average, took home $464 million apiece in 2008. Yes, that was an average of $464 million amongst the top 25 hedge fund managers.